Website value calculator & SEO Checker => nccn.org
SEO report with information and free domain appraisal for nccn.org. It is a domain hosted in . Its server is hosted on IP 67.216.68.28. The domain is ranked at the number 27679 as a world ranking of web pages. According to estimated data we have access to potential gains of this site are 1755 dollars per month. In annual terms, the domain nccn.org could be earning more than 21058 dollars. If someone wanted to buy the domain a good selling price would be 210581 dollars.
These data are estimated and can not be taken as 100 % real. Only give an estimate of profits depending on the subject and the traffic generated by nccn.org . The estimated number of unique visitors accessing nccn.org is 15333. Thus the total number of people who visit this page per month would be 459984 people.
Domain Authority
SEO Score
☰ Report Resume
- Page Speed Score
- Speed
- Page Load Time
- Current Ip of the domain: 67.216.68.28
- Charset of page: UTF-8
- Total Keywords: 1312
- Total Links: Anchor textTypeLinkfollow/homeNavbarfollow#Aboutfollow/home/aboutDonatefollow/home/donateNewsfollow/home/newsStorefollow/home/storefollow#Loginfollow/nccn/loginMy Pagesfollow#Subscriptionsfollow/home/store/subscriptionsOrder Historyfollow/home/store/order-historyAccount Settingsfollow#Edit Accountfollow/profileLog Outfollow/Sitefinity/SignOut?redirect_uri=%2FNavbarfollow#Guidelinesfollow#Compendia & Templatesfollow#Education & Researchfollow#Patient Resourcesfollow/patientresources/patient-resourcesBusiness & Policyfollow#Globalfollow#Guidelinesfollow#COVID-19 Resourcesfollow/covid-19Treatment by Cancer Typefollow/guidelines/category_1Detection, Prevention, and Risk Reductionfollow/guidelines/category_2Supportive Carefollow/guidelines/category_3Specific Populationsfollow/guidelines/category_4Guidelines for Patientsfollow/guidelines/patientsGuidelines With Evidence Blocksfollow/guidelines/guidelines-with-evidence-blocksFramework for Resource Stratificationfollow/guidelines/nccn-framework-for-resource-stratification-of-nccn-guidelinesHarmonized Guidelinesfollow/global/what-we-do/harmonized-guidelinesInternational Adaptations and Translationsfollow/global/what-we-do/international-adaptations-and-translationsGuidelines Processfollow/guidelines/guidelines-process/about-nccn-clinical-practice-guidelinesGuidelines Panels and Disclosurefollow/guidelines/guidelines-panels-and-disclosure/disclosure-policies-and-potential-conflicts-of-interestSubmissions, Licensing, and Permissionsfollow/guidelines/submissions-licensing-and-permissions/licensing-and-permissionsRecently Updated Guidelinesfollow/guidelines/recently-published-guidelinesAcute Lymphoblastic Leukemiafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1410Acute Myeloid Leukemiafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1411Anal Carcinomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1414Basal Cell Skin Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1416B-Cell Lymphomasfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1480Bladder Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1417Bone Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1418Breast Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1419Central Nervous System Cancersfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1425Cervical Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1426Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1478Chronic Myeloid Leukemiafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1427Colon Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1428Dermatofibrosarcoma Protuberansfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1430Esophageal and Esophagogastric Junction Cancersfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1433Gastric Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1434Gastrointestinal Stromal Tumors (GIST)follow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1507Gestational Trophoblastic Neoplasiafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1489Hairy Cell Leukemiafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1481Head and Neck Cancersfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1437Hepatobiliary Cancersfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1438Histiocytic Neoplasmsfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1502Hodgkin Lymphomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1439Kaposi Sarcomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1485Kidney Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1440Malignant Pleural Mesotheliomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1442Melanoma: Cutaneousfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1492Melanoma: Uvealfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1488Merkel Cell Carcinomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1444Multiple Myelomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1445Myelodysplastic Syndromesfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1446Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Fusion Genesfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1505Myeloproliferative Neoplasmsfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1477Neuroendocrine and Adrenal Tumorsfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1448Non-Small Cell Lung Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1450Occult Primaryfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1451Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1453Pancreatic Adenocarcinomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1455Pediatric Acute Lymphoblastic Leukemiafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1496Pediatric Aggressive Mature B-Cell Lymphomasfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1504Pediatric Hodgkin Lymphomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1498Penile Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1456Primary Cutaneous Lymphomasfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1491Prostate Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1459Rectal Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1461Small Bowel Adenocarcinomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1495Small Cell Lung Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1462Soft Tissue Sarcomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1464Squamous Cell Skin Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1465Systemic Light Chain Amyloidosisfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1467Systemic Mastocytosisfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1490T-Cell Lymphomasfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1483Testicular Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1468Thymomas and Thymic Carcinomasfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1469Thyroid Carcinomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1470Uterine Neoplasmsfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1473Vulvar Cancerfollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1476Waldenström Macroglobulinemia / Lymphoplasmacytic Lymphomafollow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1475Wilms Tumor (Nephroblastoma)follow/guidelines/nccn-guidelines/guidelines-detail?category=1&id=1500Breast Cancer Risk Reductionfollow/guidelines/nccn-guidelines/guidelines-detail?category=2&id=1420Breast Cancer Screening and Diagnosisfollow/guidelines/nccn-guidelines/guidelines-detail?category=2&id=1421Colorectal Cancer Screeningfollow/guidelines/nccn-guidelines/guidelines-detail?category=2&id=1429Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreaticfollow/guidelines/nccn-guidelines/guidelines-detail?category=2&id=1503Genetic/Familial High-Risk Assessment: Colorectalfollow/guidelines/nccn-guidelines/guidelines-detail?category=2&id=1436Lung Cancer Screeningfollow/guidelines/nccn-guidelines/guidelines-detail?category=2&id=1441Prostate Cancer Early Detectionfollow/guidelines/nccn-guidelines/guidelines-detail?category=2&id=1460Adult Cancer Painfollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1413Antiemesisfollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1415Cancer-Associated Venous Thromboembolic Diseasefollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1423Cancer-Related Fatiguefollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1424Distress Managementfollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1431Hematopoietic Cell Transplantationfollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1501Hematopoietic Growth Factorsfollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1493Management of Immunotherapy-Related Toxicitiesfollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1486Palliative Carefollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1454Prevention and Treatment of Cancer-Related Infectionsfollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1457Smoking Cessationfollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1463Survivorshipfollow/guidelines/nccn-guidelines/guidelines-detail?category=3&id=1466Adolescent and Young Adult (AYA) Oncologyfollow/guidelines/nccn-guidelines/guidelines-detail?category=4&id=1412Cancer in People with HIVfollow/guidelines/nccn-guidelines/guidelines-detail?category=4&id=1487Older Adult Oncologyfollow/guidelines/nccn-guidelines/guidelines-detail?category=4&id=1452Acute Lymphoblastic Leukemia (adult)follow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=1Acute Lymphoblastic Leukemia (pediatric)follow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=48Acute Myeloid Leukemiafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=2Adolescents and Young Adults with Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=3Anal Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=58Anemia and Neutropenia - Low Red and White Blood Cell Countsfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=57Basal Cell Skin Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=60B-Cell Lymphomas - Diffuse Large B-Cell Lymphomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=9B-Cell Lymphomas - Follicular Lymphomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=13B-Cell Lymphomas - Mantle Cell Lymphomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=20Bladder Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=4Bone Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=51Brain Cancer - Gliomasfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=5Breast Cancer - DCIS Breast Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=30Breast Cancer - Invasive Breast Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=16Breast Cancer - Metastatic Breast Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=22Central Nervous System Cancers - Primary Central Nervous System Lymphomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=53Chronic Lymphocytic Leukemiafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=6Chronic Myeloid Leukemiafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=7Colon Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=8Distress Management - Distress During Cancer Carefollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=10Esophageal Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=12Gallbladder and Bile Duct Cancersfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=47Head and Neck Cancers - Nasopharyngeal Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=43Head and Neck Cancers - Oral Cancersfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=31Head and Neck Cancers - Oropharyngeal Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=44Hodgkin Lymphomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=15Immunotherapy Side Effects: CAR T-Cell Therapyfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=45Immunotherapy Side Effects: Immune Checkpoint Inhibitorsfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=46Kidney Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=17Liver Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=14Lung Cancer Screeningfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=18Malignant Pleural Mesotheliomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=19Melanomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=21Multiple Myelomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=24Mycosis Fungoides/Sézary Syndromefollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=25Myelodysplastic Syndromesfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=26Myeloproliferative Neoplasmsfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=27Nausea and Vomitingfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=28Neuroendocrine Tumorsfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=29Non-Small Cell Lung Cancer - Early and Locally Advancedfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=11Non-Small Cell Lung Cancer - Metastaticfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=23Ovarian Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=32Pancreatic Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=33Primary Cutaneous Lymphomasfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=55Prostate Cancer: Advanced Stagefollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=50Prostate Cancer: Early Stagefollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=49Rectal Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=36Small Cell Lung Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=59Soft Tissue Sarcomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=37Squamous Cell Skin Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=38Stomach Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=39Survivorship Care for Cancer-Related Late and Long-Term Effectsfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=54Survivorship Care for Healthy Livingfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=52T-Cell Lymphomas - Peripheral T-Cell Lymphomafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=34Thyroid Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=40Uterine Cancerfollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=41Waldenström Macroglobulinemiafollow/patientresources/patient-resources/guidelines-for-patients/guidelines-for-patients-details?patientGuidelineId=42About Clinical Practice Guidelinesfollow/guidelines/guidelines-process/about-nccn-clinical-practice-guidelinesDevelopment and Update of Guidelinesfollow/guidelines/guidelines-process/development-and-update-of-guidelinesTransparency Processfollow/guidelines/guidelines-process/transparency-process-and-recommendationsGuidelines Panels Meeting Schedulefollow/guidelines/guidelines-process/guidelines-panels-scheduleDisclosure Policies and Potential Conflicts of Interestfollow/guidelines/guidelines-panels-and-disclosure/disclosure-policies-and-potential-conflicts-of-interestGuidelines Panelsfollow/guidelines/guidelines-panels-and-disclosure/disclosure-panelsGuideline Steering Committeefollow/guidelines/guidelines-panels-and-disclosure/guideline-steering-committeeLicensing and Permissionsfollow/guidelines/submissions-licensing-and-permissions/licensing-and-permissionsPermissions Linkingfollow/guidelines/submissions-licensing-and-permissions/permissions-linkingPermissions Distress Toolfollow/guidelines/submissions-licensing-and-permissions/permissions-distress-toolPermissions Request Formfollow/guidelines/submissions-licensing-and-permissions/permissions-request-formSubmission Request to the Guidelines Panelsfollow/guidelines/submissions-licensing-and-permissions/submissions-request-to-the-guidelines-panelsSubmission Request Historyfollow/guidelines/submissions-licensing-and-permissions/submission-request-historyAcademic Publication Informationfollow/guidelines/submissions-licensing-and-permissions/academic-publication-informationCompendia & Templatesfollow#Compendiafollow/compendia-templates/compendia/nccn-compendiaChemotherapy Order Templatesfollow/compendia-templates/nccn-templates-main/browse-by-cancer-typeNCCN Compendiafollow/compendia-templates/compendia/nccn-compendiaDrugs and Biologics Compendiumfollow/compendia-templates/compendia/drugs-and-biologics-compendiaBiomarkers Compendiumfollow/compendia-templates/compendia/biomarkers-compendiumImaging AUC Compendiumfollow/compendia-templates/compendia/imaging-appropriate-use-criteria-nccn-imaging-aucRadiation Therapy Compendiumfollow/compendia-templates/compendia/radiation-therapycompendiumSubscribe to NCCN Compendiumfollow/home/storeRecognition Programfollow/compendia-templates/compendia/recognition-programBrowse by Cancer Typefollow/compendia-templates/nccn-templates-main/browse-by-cancer-typeView Chemotherapy Order Templates User Guidefollowhttps://www.nccn.org/docs/default-source/nccn-documents/nccn-chemotherapy-templates-user-guide.pdfEHR Integrationfollow/compendia-templates/nccn-templates-main/ehr-integrationChemotherapy Order Templates Committeefollow/compendia-templates/nccn-templates-main/nccn-chemotherapy-order-templates-committeeSubscribe to NCCN Templatesfollow/compendia-templates/nccn-templates-main/subscribe-to-templatesChemotherapy Order Templates Reviewer Acknowledgementfollow/compendia-templates/nccn-templates-main/nccn-chemotherapy-order-reviewer-engagementEducation & Researchfollow#Events and Programsfollow/education-research/educational-events-and-programs/calendar-of-eventsOncology Research Programfollow/education-research/nccn-oncology-research-program/orp-main-pageJNCCNfollow/education-research/jnccn/about-jnccnPublicationsfollow/education-research/publicationsContinuing Educationfollowhttps://education.nccn.orgCalendar of Eventsfollow/education-research/educational-events-and-programs/calendar-of-eventsAnnual Conferencefollow/education-research/educational-events-and-programs/annual-conferenceAnnual Congress: Hematologic Malignanciesfollow/education-research/educational-events-and-programs/annual-congress-hematologic-malignanciesOncology Research Program (ORP)follow/education-research/nccn-oncology-research-program/orp-main-pageCurrent Opportunitiesfollowhttp://www.nccn.org/education-research/nccn-oncology-research-program/orp-main-page#current-opportunitiesORP Recent Newsfollow/education-research/nccn-oncology-research-program/orp-recent-newsORP Grant Historyfollow/education-research/nccn-oncology-research-program/orp-grant-historyScientific Publicationsfollow/education-research/nccn-oncology-research-program/scientific-publicationsClinical Trialsfollow/education-research/nccn-oncology-research-program/clinical-trialsYoung Investigator Awardsfollow/education-research/nccn-oncology-research-program/young-investigator-awardsInformed Consent Language Databasefollow/education-research/nccn-oncology-research-program/informed-consent-language-databaseBest Practices for Biorepositoriesfollow/education-research/nccn-oncology-research-program/best-practices-for-biorepositoriesShared Resourcesfollow/education-research/nccn-oncology-research-program/shared-resourcesDisclosure Policyfollow/education-research/nccn-oncology-research-program/disclosure-policyAbout JNCCNfollow/education-research/jnccn/about-jnccnSubscribe to JNCCNfollow/education-research/jnccn/jnccn-subscribeJNCCN Email Updatesfollow/education-research/jnccn/jnccn-email-updatesBusiness & Policyfollow#Businessfollow/business-policy/business/corporate-councilPolicy and Advocacy Programfollow/business-policy/policy-and-advocacy-program/nccn-policy-and-advocacy-programCorporate Councilfollow/business-policy/business/corporate-councilAcademyfollow/business-policy/business/academyTrends U.S. Surveysfollow/business-policy/business/trends-u.s.-surveysTrends Global Surveysfollow/global/opportunities/nccn-trendsFlash Updatesfollow/business-policy/business/flash-updatesOrder Free Pocket Guidelines and Guidelines for Patientsfollowhttp://promail.nicelines.com/v5fmsnet/oe.asp?pos=NCCN01&v=9Advertising Opportunitiesfollow/business-policy/business/advertising-opportunitiesResearch Tools: REMSfollow/business-policy/business/research-tools-remsEmployer Toolkitfollow/business-policy/business/employer-resources/employer-toolkitEmployer Resourcesfollow/business-policy/business/employer-resourcesVirtual Reimbursement Resource Room and Appfollow/business-policy/business/virtual-reimbursement-resource-room-and-appHealth Information Technology Licensesfollow/business-policy/business/health-information-technology-licensesEmbargo Policyfollow/business-policy/business/embargo-policyFirewall Policyfollow/business-policy/business/firewall-policyPolicy and Advocacy Programfollow/business-policy/policy-and-advocacy-program/nccn-policy-and-advocacy-programOncology Policy Summitsfollow/business-policy/policy-and-advocacy-program/oncology-policy-summitsPolicy Priority: Improve and Facilitate Quality Cancer Carefollow/business-policy/policy-and-advocacy-program/policy-priority-improve-and-facilitate-quality-of-cancer-carePolicy Priority: Ensure Patient Accessibilityfollow/business-policy/policy-and-advocacy-program/policy-priority-ensure-patient-accessibilityPolicy Priority: Increase Use of Guidelinesfollow/business-policy/policy-and-advocacy-program/policy-priority-increase-use-of-nccn-guidelinesState Oncology Society Forumfollow/business-policy/policy-and-advocacy-program/state-oncology-society-forumGlobalfollow#Global Clinical Resourcesfollow/global/what-we-doGlobal Support Opportunitiesfollow/global/opportunitiesContact NCCN Globalfollow/global/contact-nccn-globalGlobal Eventsfollow/global/global-eventsNCCN Framework For Resource Stratificationfollow/guidelines/nccn-framework-for-resource-stratification-of-nccn-guidelinesHarmonized Guidelinesfollow/global/what-we-do/harmonized-guidelinesInternational Adaptations and Translationsfollow/global/what-we-do/international-adaptations-and-translationsRegionsfollow/global/what-we-do/regions/africaGlobal Corporate Councilfollow/global/opportunities/supportersGlobal Academyfollow/global/opportunities/global-academyTrends Global Surveysfollow/global/opportunities/nccn-trendseBulletin Global Editionfollow/home/news/newsletters/ebulletin-global-editionfollow/business-policy/policy-and-advocacy-program/oncology-policy-summitsfollow/education-research/educational-events-and-programs/annual-conferencefollowhttps://web.cvent.com/event/a51b1fcd-7dcc-4c7b-886c-cf62dcc5d873/summaryLog-Infollow/loginRegisterfollowhttps://www.nccn.org/registerCOVID-19 Resourcesfollow/covid-19NCCN Guidelines & Derivativesfollow/guidelines/category_1follow/guidelines/category_1Continuing Educationfollow/education-research/educational-events-and-programs/calendar-of-eventsfollow/education-research/educational-events-and-programs/calendar-of-eventsPolicyfollow/business-policy/policy-and-advocacy-program/nccn-policy-and-advocacy-programfollow/business-policy/policy-and-advocacy-program/nccn-policy-and-advocacy-programBusinessfollow/business-policy/business/corporate-councilfollow/business-policy/business/corporate-councilOncology Research Programfollow/education-research/nccn-oncology-research-program/orp-main-pagefollow/education-research/nccn-oncology-research-program/orp-main-pageGlobalfollow/global/what-we-dofollow/global/what-we-doSee All NCCN Member Institutionsfollow/home/member-institutions/follow/members/profile?GroupId=2451follow/members/profile?GroupId=706follow/members/profile?GroupId=2follow/members/profile?GroupId=6follow/members/profile?GroupId=7follow/members/profile?GroupId=9follow/members/profile?GroupId=29follow/members/profile?GroupId=8follow/members/profile?GroupId=10follow/members/profile?GroupId=485follow/members/profile?GroupId=15follow/members/profile?GroupId=14follow/members/profile?GroupId=26follow/members/profile?GroupId=12follow/members/profile?GroupId=18follow/members/profile?GroupId=19follow/members/profile?GroupId=20follow/members/profile?GroupId=22follow/members/profile?GroupId=16follow/members/profile?GroupId=11follow/members/profile?GroupId=13follow/members/profile?GroupId=2986follow/members/profile?GroupId=399follow/members/profile?GroupId=2753follow/members/profile?GroupId=28follow/members/profile?GroupId=400follow/members/profile?GroupId=24follow/members/profile?GroupId=934follow/members/profile?GroupId=2752follow/members/profile?GroupId=30follow/members/profile?GroupId=486Register Now! NCCN 2021 Virtual Congress: Biomarkers in Solid Tumorsfollowhttps://cvent.me/Qr7aOWEVENT DETAILSfollowhttps://cvent.me/Qr7aOWMonthly Oncology Tumor Boards: Updates in the Management of Pancreatic Cancerfollowhttps://education.nccn.org/node/90701EVENT DETAILSfollowhttps://education.nccn.org/node/90701Patient Webinar: Multiple Myelomafollowhttps://www.nccn.org/patientresources/patient-resources/patient-webinars/multiple-myelomaEVENT DETAILSfollowhttps://www.nccn.org/patientresources/patient-resources/patient-webinars/multiple-myelomaNCCN Pharmacy Updates™: The Evolving Landscape of Maintenance Therapy for Ovarian Cancerfollowhttps://education.nccn.org/node/90674EVENT DETAILSfollowhttps://education.nccn.org/node/90674Patient Webinar: Multiple Myelomafollowhttps://www.nccn.org/patientresources/patient-resources/patient-webinars/multiple-myelomaEVENT DETAILSfollowhttps://www.nccn.org/patientresources/patient-resources/patient-webinars/multiple-myelomaView all Upcoming Events!followhttps://www.nccn.org/education-research/educational-events-and-programs/calendar-of-eventsVIEW ALL EVENTSfollowhttps://www.nccn.org/education-research/educational-events-and-programs/calendar-of-eventsView Patient Resourcesfollow/patientresources/patient-resourcesDonate to NCCN Foundationfollowhttps://nccnfoundation.givingfuel.com/nccn-foundationNavbarfollow#End User License Agreementfollow/footermenu/end-user-license-agreementPrivacy Policyfollow/footermenu/privacy-policyLegal Noticesfollow/footermenu/legal-noticesAccessibilityfollow/footermenu/accessibilitySupport NCCNfollow/footermenu/support-nccnDeveloper APIfollow/footermenu/developer-apiContactfollow/footermenu/contactfollowhttps://www.facebook.com/NCCNorgfollowhttps://twitter.com/NCCNfollowhttps://www.instagram.com/NCCNorgfollowhttps://www.linkedin.com/company/nccnfollowhttps://www.youtube.com/NCCNvideoLegal Noticesfollow/legal-notices
- Social signals
- Title: 49 characters.
- Description: 254 characters.
- Domain Authority
- Monthly pages viewed: 459984
- Estimated worth: 210581 dollars
We have developed a useful service for retrieve WhoIs information. "Whois" is a term that begins from the early days of the Internet, based on Unix operating system and university networks. On the Unix console, the command "whois" tries to determine the identity of the domain's registrant.
It is a means for Internet users to query various types of information such as IP addresses, user data and also domain data.
✦ SEO Report
Title / Meta tags
National Comprehensive Cancer Network - Home
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 31 leading cancer centers devoted to patient care, research, and education, is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer
Image Analysis
A right example for an HTML image tag:
<img src="prettyimage.jpg" alt="image description" title="image tooltip"/>
For SEO performance, you must write an alternative text. The alternative text must describe the image's content. Also, the alt tag is used for blind people. Their browsers tell them all about the description of the image.
Heading
Content Analysis
Code Analysis
We have not found hyphens (-) or underscores (_) in your URL. Google and expert domainers do not recommend buying domains with hyphens or underscores.
When a visitor came to your website you can not fail. The user wants your page to load in a second. You know that it is difficult sometimes to display content in the first second but if the user has to wait too much time you can lose that user. If your page is too slow, you will lose a lot of web traffic. Your project URL load time is ms, it is class speed. This speed not fine and need to be improved. It is over the average. Our Speed analyzer has shown that www.nccn.org is as follows:
A huge portion of visitors to your website are usually in rush and nobody is fond of waiting too much before your website loads its content. If your website is slow, you will lose a lot of visitors. Your homepage load time is ms is class speed. This speed not fine and need to be improved. It is over the average. Our Speed analyzer has shown that www.nccn.org is as follows:
Speed:
Page Load Time: ms
container-fluid, row header, sf_colsIn col-lg-12 p-0, top, common-loading, common-loading-img, sf_colsIn container, row menu-top, sf_colsIn col-auto mr-auto, menu-logo, sf_colsIn col-auto, navbar-top, navbar navbar-expand-md navbar-light, navbar-brand, navbar-toggler, navbar-toggler-icon, collapse navbar-collapse, navbar-nav flex-wrap, nav-item , nav-link, sf_colsIn col-xs-12 col-sm-auto, row, sf_colsIn col-xs-12 col-sm-auto col-auto search, form-inline, form-group sf-search-input-wrapper, form-control, btn btn-primary, sf_colsIn col-xs-12 col-sm-auto login, navbar navbar-expand-lg container, collapse navbar-collapse show, navbar-nav mr-auto, nav-item dropdown, nav-link top-link, mr-2 nav-link top-link, dropdown-menu, container, col, title-text, mr-2 link-text, row border-top justify-content-end, col-3 text-right pr-0 mt-3, logout-text, sf_colsIn col-lg-12, navbar navbar-expand-lg container navbar-light, navbar-toggler collapsed ml-auto, navbar-nav mr-auto flex-wrap, nav-link dropdown-toggle top-link, nav-item, dropdown-menu level-2, col-3, dropdown-item, dropdown-item dropdown-toggle, col-9 dropdown-menu level-3, col-4, image-rotator, banner current, banner next, banner , row white-background, row welcome justify-content-center, col-12 title-text, col-12 content-text, col-6 content-text, col-12 link-text, button-register, row gray-background education-research, primary-topic noIcon, sf_colsIn col-lg-4, primary-topic , col-auto ml-auto, row white-background member-institution, sf_colsIn container text-center, row content-container, col-9 content-text, col-12 text-center link-text, row justify-content-md-center, col-12, row flex-row flex-nowrap, col-12 col-sm-3 col-lg-2, card-img-top, scroller scroller-left, scroller scroller-right, w-100 nccn-h2, col-12 col-md-6 col-lg-4 event-item, card card-preview clickable, card-body, card-title nccn-h3, nccn-h4-gray mb-0, card-footer link, row nccn-foundation, col-12 col-md-6 align-self-center, col-11 content-text, col-8 col-md-6 align-self-center, row nccnSiteSupporters, webSpprtrsImg, row footer, menu-footer text-center, footer-contact, col-12 text-center, col-6 text-right, col-6 text-keft, row justify-content-center social, col-auto, list-unstyled, social-facebook, social-twitter, icon, social-instagram, social-linkedin, social-youtube, row footer-copyright, col text-center,
How much money does nccn.org earn?
The domain nccn.org has a revenue of $1609.944 monthly. We have calculated this earning based on the daily traffic of this domain.
Has nccn.org Google Analytics code?
The domain nccn.org has the Google Analytics code inside its HTML.
Has nccn.org Google Adsense code?
The Analytics id for nccn.org is 3421690
.
The domain nccn.org has not the Google Adsense code inside its HTML.
What IP nccn.org has?
The domain nccn.org has IP 67.216.68.28.
Which charset nccn.org has?
An IP address is a string of numbers used to make devices accessible for communication.
The domain nccn.org has the charset UTF-8.
How many internal links nccn.org has?
To display an HTML page correctly, a web browser must know which character set to use.
The charset change for every language set of characters like English, Chinese or Russian.
The domain nccn.org has 0 links.
How many words nccn.org has?
The links are an important part of the web.
The links help us to navigate between pages.
The domain nccn.org has 1312 words.
The number of words is a crucial metric of the website.
The websites need a large quantity of text to explain the content of the site
Last visited